MedPath

Clinical efficacy of Xiaoyu powder combined with traditional Chinese and Western medicine in the treatment of primary osteoporosis with low back pai

Not Applicable
Not yet recruiting
Conditions
osteoporosis
Registration Number
ITMCTR2000003699
Lead Sponsor
Xinhua Hospital Affiliated to Medical College of Shanghai Jiaotong University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

(1) According to the diagnostic criteria of osteoporosis in Western Medicine (brittle fracture or / and t value <= - 2.5);
(2) Accompanied with low back pain and pain time >=1 month;
(3) No anti osteoporosis treatment or drugs affecting bone mineral density (BMD) were used in the past month;
(4) Volunteer to participate in clinical trials and sign informed consent.

Exclusion Criteria

(1) Secondary osteoporosis;
(2) Relevant treatment has been carried out recently;
(3) Allergic to related drugs;
(4) Patients with severe heart disease, severe liver and kidney dysfunction, malignant hypertension, severe heart failure, severe arrhythmia, lumbar or hip implants, osteomalacia, primary hyperparathyroidism, diabetes, psychosis and other diseases affecting bone metabolism;
(5) Unwilling to participate in clinical trials.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.